Status:
UNKNOWN
Intravenous Artesunate and Malaria
Lead Sponsor:
University of Khartoum
Collaborating Sponsors:
University of Kassala, Sudan
Kassala
Conditions:
Malaria
Eligibility:
All Genders
1-80 years
Phase:
PHASE4
Brief Summary
Intravenous artesunate is egual to quinine in the treatment of severe malaria
Detailed Description
Intravenous artesunate is egual to quinine in the treatment of severe malaria in the form of fever clearance time and parasite clearance time
Eligibility Criteria
Inclusion
- severe P.falciparum malaria-
Exclusion
- mixed infection Pregnant women -
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01805232
Start Date
March 1 2013
End Date
July 1 2013
Last Update
March 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kassala
Kassala, Kassala, Sudan, 249